An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis
Gardiner PV, Sykes HR, Hassey GA, Walker DJ. An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol 1993;32:724-728.
Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: Results of short-term clinical trials and observational studies versus long-term observational studies
Hawley DJ, Wolfe F. Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: Results of short-term clinical trials and observational studies versus long-term observational studies. Arthritis Care Res 1992;5:130-136.
The long-term outcomes of rheumatoid arthritis: Work disability - A prospective 18 year study of 823 patients
Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: Work disability - A prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-2117.
Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-1582.
The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis
Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-1082.
The total costs of drug therapy for rheumatoid arthritis: A model based on costs of drug, monitoring, and toxicity
Prashker MJ, Meenan RF. The total costs of drug therapy for rheumatoid arthritis: A model based on costs of drug, monitoring, and toxicity. Arthritis Rheum 1995;38:318-325.